Literature DB >> 24637422

Prostate cancer: a consensus on trial design for focal therapy.

Sangeet Ghai1, John Trachtenberg2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24637422     DOI： 10.1038/nrurol.2014.64

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

1.  Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy.

Authors:  Uri Lindner; Nathan Lawrentschuk; Robert A Weersink; Sean R H Davidson; Orit Raz; Eugen Hlasny; Deanna L Langer; Mark R Gertner; Theodorus Van der Kwast; Masoom A Haider; John Trachtenberg
Journal:  Eur Urol       Date:  2010-03-12       Impact factor: 20.096

2.  Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.

Authors:  David G Bostwick; David J Waters; Edward R Farley; Isabelle Meiers; Daniel Rukstalis; William A Cavanaugh; Haakon Ragde; Martin K Dineen; Duke Bahn; Stephen Scionti; Richard Babian; David S Ellis; John C Rewcastle; Harry B Burke; Gerald L Andriole; Gary Onik; Al E Barqawi; John Maksem; Winston E Barzell
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

3.  Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer.

Authors:  Orit Raz; Masoom A Haider; Sean R H Davidson; Uri Lindner; Eugen Hlasny; Robert Weersink; Mark R Gertner; Walter Kucharczyk; Walter Kucharcyzk; Stuart A McCluskey; John Trachtenberg
Journal:  Eur Urol       Date:  2010-03-12       Impact factor: 20.096

4.  Evaluating localized prostate cancer and identifying candidates for focal therapy.

Authors:  A Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Jonathan Coleman; David F Penson; Peter R Carroll; Mark A Rubin; Peter T Scardino
Journal:  Urology       Date:  2008-12       Impact factor: 2.649

5.  Focal magnetic resonance guided focused ultrasound for prostate cancer: Initial North American experience.

Authors:  Uri Lindner; Sangeet Ghai; Paula Spensieri; Eugen Hlasny; Theodorus H Van Der Kwast; Stuart A McCluskey; Masoom A Haider; Walter Kucharczyk; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

6.  MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.

Authors:  Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee; Sam Soo Kim; EunJu Kim
Journal:  AJR Am J Roentgenol       Date:  2008-05       Impact factor: 3.959

7.  Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.

Authors:  Deanna L Langer; Theodorus H van der Kwast; Andrew J Evans; Laibao Sun; Martin J Yaffe; John Trachtenberg; Masoom A Haider
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

Review 8.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Authors:  Scott E Eggener; Peter T Scardino; Peter R Carroll; Michael J Zelefsky; Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Samson W Fine; John Trachtenberg; Mark A Rubin; Mak Ohori; Kentaro Kuroiwa; Michel Rossignol; Lucien Abenhaim
Journal:  J Urol       Date:  2007-10-15       Impact factor: 7.450

9.  Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.

Authors:  Willemien van den Bos; Berrend G Muller; Hashim Ahmed; Chris H Bangma; Eric Barret; Sebastien Crouzet; Scott E Eggener; Inderbir S Gill; Steven Joniau; Gyoergy Kovacs; Sascha Pahernik; Jean J de la Rosette; Olivier Rouvière; Georg Salomon; John F Ward; Peter T Scardino
Journal:  Eur Urol       Date:  2014-01-13       Impact factor: 20.096
  9 in total
  3 in total

1.  3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy.

Authors:  Clément Orczyk; Andrew B Rosenkrantz; Artem Mikheev; Arnauld Villers; Myriam Bernaudin; Samir S Taneja; Samuel Valable; Henry Rusinek
Journal:  Acad Radiol       Date:  2017-11-06       Impact factor: 3.173

2.  Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.

Authors:  Sangeet Ghai; Nathan Perlis; Uri Lindner; Eugen Hlasny; Masoom A Haider; Antonio Finelli; Alexandre R Zlotta; Girish S Kulkarni; Theodorus H van der Kwast; Stuart A McCluskey; Walter Kucharczyk; John Trachtenberg
Journal:  Eur Radiol       Date:  2018-04-25       Impact factor: 5.315

Review 3.  MRI-guided biopsies and minimally invasive therapy for prostate cancer.

Authors:  Sangeet Ghai; John Trachtenberg
Journal:  Indian J Urol       Date:  2015 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.